ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease. [PDF]
Wang Z +9 more
europepmc +1 more source
Association of ADAMTS-5 gene polymorphisms with the susceptibility to knee osteoarthritis in a Chinese Han population. [PDF]
Gao S +8 more
europepmc +1 more source
Translational pharmacokinetic and pharmacodynamic modelling of the anti-ADAMTS-5 NANOBODY<sup>®</sup> (M6495) using the neo-epitope ARGS as a biomarker. [PDF]
Pereira JNS +5 more
europepmc +1 more source
Erratum: Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles. Biomolecules 2020, 10, 416. [PDF]
Addinsall AB +7 more
europepmc +1 more source
ADAMTS-9 in Mouse Cartilage Has Aggrecanase Activity That Is Distinct from ADAMTS-4 and ADAMTS-5. [PDF]
Rogerson FM +6 more
europepmc +1 more source
Safety, Tolerability, and Pharmacodynamics of the ADAMTS-5 Nanobody M6495: Two Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies in Healthy Subjects and Patients With Osteoarthritis. [PDF]
Bihlet AR +10 more
europepmc +1 more source
Matrix-degrading protease ADAMTS-5 cleaves inter-α-inhibitor and releases active heavy chain 2 in synovial fluids from arthritic patients. [PDF]
Scavenius C +8 more
europepmc +1 more source
Effect of Mechanical Stress in Combination with Verapamil on Levels of Aggrecan and ADAMTS-5 mRNAs and Proteins in Human Osteoarthritic Chondrocyte/Agarose Constructs. [PDF]
Luo D +8 more
europepmc +1 more source
Screening for selective ADAMTS-5 substrates to monitor proteinase activity
openaire +2 more sources
ADAMTS-5 takes centre stage in new developments for aggrecanase inhibitors
openaire +3 more sources

